NEW YORK (GenomeWeb) – Genomic Vision today announced that it has signed an agreement with APG Bio to distribute Genomic Vision's products and services to life science researchers in China, Hong Kong, and Macau.

Bagneux, France-based Genomic Vision markets its DNA Molecular Combing technology for genetic research applications including gene editing. It also provides a variety of molecular diagnostic tests for breast, ovarian, and colorectal cancers.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.